2006
DOI: 10.1089/ten.2007.13.ft-312
|View full text |Cite
|
Sign up to set email alerts
|

Structural Bone Allograft Combined with Genetically Engineered Mesenchymal Stem Cells As a Novel Platform for Bone Tissue Engineering

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
15
0
1

Year Published

2007
2007
2020
2020

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 34 publications
2
15
0
1
Order By: Relevance
“…Recently, advances in gene delivery techniques have made possible the use of BMPs in combination with osteogenic cells to treat bone allografts with encouraging results in allograft healing and integration. 5,34,48,49 A combination of these therapies is a promising strategy that improves the osteogenic and osteoinductive potential of structural bone allografts.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, advances in gene delivery techniques have made possible the use of BMPs in combination with osteogenic cells to treat bone allografts with encouraging results in allograft healing and integration. 5,34,48,49 A combination of these therapies is a promising strategy that improves the osteogenic and osteoinductive potential of structural bone allografts.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, it has also been documented that by seeding BMP2 modified cells directly onto an allograft, cartilaginous tissue and a new cortical shell were formed resulting in bridging of a segmental defect. However, this did not completely mimic an autograft as slower resorption of the graft was observed [103]. More recently it has been reported that BM-MSC cell sheets can act as an engineered periosteum and promote bone callus formation during allograft healing [104], while PDC cell sheets may have applications in tendon-bone healing [105].…”
Section: Tissue Engineering Strategies Mimicking the Periosteum In Itmentioning
confidence: 99%
“…For these studies we chose to use the C3H10T1/2 cell line, since it is representative of the mesenchymal progenitor cell targets of the gene therapy and has been demonstrated to mediate efficient bone formation in vivo when transfected with osteogenic genes [22,23]. (Fig.…”
Section: Effects Of Surface Demineralization On Raav-luc Transductionmentioning
confidence: 99%